Usefulness of skin phototype as a parameter of phototoxicity after oral or topical administration of psoralen in patients before PUVA therapy;Wartość fototypu skóry w przewidywaniu odczynu fototoksycznego po doustnym i ka̧pielowym zastosowaniu psoralenu u pacjentów przed planowana̧ PUVA-terapia̧

Przeglad Dermatologiczny

Volumn 96, Issue 4, 2009, Pages 255-263

  Chabior, Alina ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Minimal phototoxic dose; Photochemotherapy; Skin phototype

Indexed keywords

BERGAPTEN; METHOXSALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CUTANEOUS PARAMETERS; HUMAN; INGESTION; MAJOR CLINICAL STUDY; PHOTOSENSITIVITY; PHOTOTHERAPY; PHOTOTOXICITY; PUVA; SCHOOL CHILD; SKIN EXAMINATION; SKIN SENSITIVITY; ULTRAVIOLET A RADIATION;

EID: 70349574142     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fitzpatrick T.B.: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988, 124, 869-871.
2. Diffey B.L., De Berker D.A., Saunders P.J., Farr P.M.: A device for phototesting patients before PUVA therapy. Br J Dermatol 1993, 129, 700-703.
3. Wolska H.: Fototerapia w dermatologii. Wydawnictwo Czelej, Lublin 2006.
4. Hönigsmann H.: Erythema and pigmentation. Photedermatol Photoimmunol Photomed 2002, 18, 75-81.
5. Park Y.K., Hann S.K., Cho M.Y., Kim H.J., Shim S.C., Choi S.J. i inni: Study of the skin concetrations after administration of the various phototoxic drugs. Yonesi Med J 1991, 32, 231-236.
6. Morison W.L.: Phototherapy and photochemotherapy of skin disease. Raven Press, New York, 1991, 93-131.
7. Sakuntabhai A., Diffey B.L., Farr P. M.: Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment. Br J Dermatol 1995, 133, 919-7, 923. (Pubitemid 26008933)
8. Goldstein D. P., Carter D.M., Ljunggren B., Burkholder J.: Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients. J Invest Dermatol 1982, 78, 429-433.
9. McLelland J., Fisher C., Farr P.M., Diffey B.L., Cox N.H.: The relationship between plasma psoralen concetration and psoralen-UVA erythema. Br J Dermatol 1991, 124, 585-590.
10. Yeo U.C., Shin J.H., Yang J.M., Park B.K., Kim M.M., Bok H.S. i inni: Psoralen-ultraviolet A- induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid. Br J Dermatol 2000, 142, 733-739.
11. Diffey B.L., Farr P.M.: The normal range in diagnostic phototesting. Br J Dermatol 1989, 120, 517-524.
12. Grundmann-Kollmann M., Podda M., Bräutigam L., Hardt-Weinelt K., Ludwig R.J., Geisslinger G. i inni: Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration. Br J Clin Pharmacol 2002, 54, 535-539.
13. Boyvat A., Erdi H., Birol A., Gurgey E.: Interaction of commonly used emollients with photochemotherapy. Photodermatol Photoimmunol Photomed 2000, 16, 156-160. (Pubitemid 30666077)
14. Collins P., Wainwright N.J., Amorim I., Lakshmipathi T., Ferguson J.: 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-base regimen with a skin-type approach. Br J Dermatol 1996, 135, 248-254.
15. Ibbotson S.H., Dawe R.S., Farr P.M.: The effect of methoxalen dose on ultraviolet-A-induced erythema. J Invest Dermatol 2001, 116, 813-815.
16. Sakuntabhai A., Mattews J.N., Farr P.M.: Improved prediction of the minimal phototoxic dose in PUVA therapy. Br J Dermatol 1994, 130, 604-609. (Pubitemid 24204697)
17. Frain-Bell W.: Treatment. Cutaneous photobiology. Oxford University Press, 1985, 170-202.
18. Gupta A.K., Anderson T. F.: Psoralen photochemotherapy. J Am Acad Dermatol 1987, 17, 703-734.
19. Man I., Dawe R.S., Ferguson J., Ibbotson S.H.: An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. Photochem Photobiol 2003, 78, 55-60.
20. Parrish J.A.: Methoxsalen-UV-A therapy of psoriasis. J Invest Dermatol 1976, 67, 669-671.
21. British Photodermatology Group: British Photodermatology Group Guidelines for PUVA. Br J Dermatol 1994, 130, 246-255.
22. Carabott F.M., Hawk J.L.: A modified dosage schedule for increased efficiency in PUVA treatment of psoriasis. Clin Exp Dermatol 1989, 14, 337-340.
23. Sakuntabhai A., Sharpe G.R., Farr P.M.: Response of psoriasis to twice weekly PUVA. Br J Dermatol 1993, 128, 166-171. (Pubitemid 23054334)
24. Wolf K., Gschnait F., Hönigsmann H., Konrad K., Parrish J.A., Fitzpatrick T.B.: Phototesting and dosimetry for photochemotherapy. Br J Dermatol 1977, 96, 1-10.
25. Ibbotson S.H., Farr P. M.: The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999, 113, 346-350. (Pubitemid 29449072)
26. Halpern S.M., Anstey A.V., Dawe R.S., Diffey B.L., Farr P.M., Ferguson J. i inni: Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group. Br J Dermatol 2000, 142, 22-31.
27. Koulu L.M., Jansén C.T.: Skin photosensitizing and Langerhans cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxyp soralen. Acta Derm Venereol (Stockh) 1983, 63, 137-141.
28. Gruss C., Behrens S., Reuther T., Husebo L., Neumann N., Altmeyer P. i inni: Kinetics of photosensitivity in bath-PUVA photochemotherapy. J Am Acad Dermatol 1998, 39, 443-446.
29. Rosen C.F., Jacques S.L., Stuart M.G., Gange R.W.: Immediate pigment darkening: visual and reflectance spectrophotometric analysis of action spectrum. Photochem Photobiol 1990, 51, 583-588.
30. Behrens-Williams S., Gruss C., Grundmann-Kollmann M., Peter R.U., Kerscher M.: Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: minimal reaction on average after 5 days. Br J Dermatol 2000, 142, 112-115.
31. Grundmann-Kollmann M., Leiter U., Behrens S., Gottlöber P., Mooser G., Krähn G. i inni: The time course of phototoxity of topical PUVA: 8- methoxypsoralen cream-PUVA vs 8- methoxypsoralen gel-PUVA. Br J Dermatol 1999, 140, 989-990. (Pubitemid 29238496)
32. Man I., Dawe R.S., Ferguson J., Ibbotson S.H.: The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen. Br J Dermatol 2004, 151, 179-182. (Pubitemid 39061296)
33. Man I., Kwok Y.K., Dawe R.S., Ferguson J., Ibbotson S.H.: The time course of topical PUVA erythema following 15- and 5- minute methoxsalen immersion. Arch Dermatol 2003, 139, 331-334.
34. Stern R.S., Momtaz K.: Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy. Arch Dermatol 1984, 120, 869-873.
35. Kraemer C.K., Menegon D.B., Cestari T.F.: Determination of the minimal phototoxic dose and colorimetry in psoralen plus ultraviolet A radiation therapy. Photodermatol Photoimmunol Photomed 2005, 21, 242-248.
36. Collins P., Rogers S.: Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 1992, 127, 392-395.
37. Lüftl M., Dagitz K., Plewig G., Röcken M.: Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 1997, 133, 1597-1603.
38. Tegeder I., Bräutigam L., Podda M., Meier S., Kaufmann R., Geisslinger G.: Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. Clin Pharmacol Ther 2002, 71, 153-161. (Pubitemid 34271118)
39. McNeely W., Goa K.L.: 5-Methoxypsoralen. A rewiew of its effects in psoriasis and vitiligo. Drugs 1998, 56, 667-690.
40. Snellman E., Rantanen T.: Concentration-dependent phototoxicity in trimethylpsoralen bath psoralen ultraviolet A. Br J Dermatol 2001, 144, 490-494. (Pubitemid 32232001)
41. Dolezal E., Seeber A., Hönigsmann H., Tanew A.: Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA. Photodermatol Photoimmunol Photomed 2000, 16, 183-185. (Pubitemid 30666082)
42. Cox N.H., Farr P.M., Diffey B.L.: A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema. Arch Dermatol 1989, 125, 1653-1657.
43. Schiener R., Behrens-Williams C.S., Pillekamp H., Peter R.U., Kerscher M.: Does the minimal phototoxic dose 8-methoxypsoralen baths correlate with the individual's skin phototype? Photodermatol Photoimmunol Photomed 2001, 17, 156-158.
44. Calzavara-Pinton P.G., Ortel B., Hönigsmann H., Zane C., De Pannus G.: Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 1994, 189, 256-259. (Pubitemid 24249640)